从重点治疗领域药物看中外新药开发之差距

The gap between Chinese and foreign drug development focused therapeutic areas

介绍了抗肿瘤药物领域、糖尿病治疗领域、循环系统疾病治疗领域的新药开发方面中外之间存在的差异。以大数据为基础的个性化医疗与干预方法,纵向一体化的产业研发联盟和以跨界资源整合为核心内容的医疗模式正在彻底改变既定思维和时空维度,"熊彼得化"(Schumpeter)成为医疗产业发展最大的特征。

The differences between Chinese and foreign in development of new drugs in the field,such as anticancer drugs,therapeutic areas of diabetes,therapeutic area of circulatory diseases were introduced.Large databased personalized medicine and interventions,alliances of vertically integrated industrial research and development and the medical model of cross-border integration of resources as the core content were revolutionizing the established thinking and spatial and temporal dimensions,＂Schumpeter＂has becoming the most important feature in the medical industry.